Related Experiment Video
Updated: Jan 30, 2026

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
Published on: November 7, 2015
The Role of Estrogen Signaling Pathway and Targeted Therapy Exploration in Urological Tumors
Cunzhen Ma1, Lin Yang1, Weijia Li1
1Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Abstract:
Estrogen signaling has emerged as a pivotal regulator in the development and progression of various cancers, including those of the urological system. While urological malignancies have traditionally been linked with androgen signaling, recent studies reveal a complex interplay where estrogen receptors-ERα, ERβ, and GPER-modulate critical cellular processes such as proliferation, apoptosis, and metastasis in these cancers. Here we show that estrogen receptors, through both genomic and non-genomic pathways, exert dual roles in either promoting or inhibiting tumor growth, making them both a challenge and a potential therapeutic target. These insights suggest that targeting estrogen receptor pathways could offer novel treatment strategies, especially for advanced or therapy-resistant urological tumors.Furthermore, understanding the molecular mechanisms through which estrogen receptors influence tumor progression could lead to the development of more specific and less toxic treatment options. The findings not only shift the paradigm of estrogen's role in cancer biology but also underscore the potential for personalized treatments, where estrogen receptor status could be used to tailor more effective and individualized therapeutic regimens. This review ushers in new possibilities for advancing urological oncology, where estrogen signaling may hold the key to overcoming current therapeutic challenges and improving clinical outcomes.
Insights
Estrogen receptors (ERα, ERβ, GPER) play dual roles in urological cancers, impacting tumor growth. Targeting these estrogen signaling pathways offers potential for novel, personalized therapies in urologic oncology.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Urological cancers traditionally linked to androgen signaling.
- Estrogen signaling is increasingly recognized as a key regulator in cancer development and progression.
- Estrogen receptors (ERα, ERβ, GPER) influence critical cellular processes like proliferation, apoptosis, and metastasis in urological malignancies.
Purpose of the Study:
- To investigate the complex roles of estrogen receptors in urological cancer.
- To explore the potential of targeting estrogen receptor pathways for novel therapeutic strategies.
- To shift the paradigm of estrogen's role in cancer biology and advance urological oncology.
Main Methods:
- Review of current literature on estrogen signaling in urological cancers.
- Analysis of genomic and non-genomic pathways modulated by estrogen receptors.
- Examination of the dual roles of estrogen receptors in tumor growth promotion and inhibition.
Main Results:
- Estrogen receptors exert dual roles, promoting or inhibiting tumor growth through both genomic and non-genomic pathways.
- Estrogen receptor status presents both a challenge and a potential therapeutic target in urological tumors.
- Targeting estrogen receptor pathways shows promise for advanced or therapy-resistant urological cancers.
Conclusions:
- Estrogen signaling is a critical factor in urological cancer progression, with complex and often opposing effects.
- Targeting estrogen receptors offers novel therapeutic avenues, potentially leading to more specific and less toxic treatments.
- Understanding estrogen receptor mechanisms can enable personalized treatment regimens for improved clinical outcomes in urological oncology.
Related Concept Videos
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Non-Canonical Wnt Signaling Pathways

